Herbas VPB

Print
EN | LT
LT - TREPROSTINIL FORMULATIONS
EN - TREPROSTINIL FORMULATIONS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 47/32 (2006.01)
A61K 47/32 (2013.01)
A61K 9/14 (2006.01)
A61K 9/10 (2013.01)
A61K 31/557 (2006.01)
A61K 45/06 (2013.01)
A61K 9/10 (2006.01)
A61K 31/785 (2013.01)
A61P 9/12 (2006.01)
A61K 47/585 (2017.08)
A61K 31/192 (2013.01)
A61P 11/00 (2018.01)
A61P 43/00 (2018.01)
A61P 9/10 (2018.01)
A61P 9/12 (2018.01)
European patent
(11) Number of the document 3164155
(13) Kind of document T
(96) European patent application number 15731463.4
Date of filing the European patent application 2015-06-12
(97) Date of publication of the European application 2017-05-10
(45) Date of publication and mention of the grant of the patent 2022-02-09
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/035595
Date 2015-06-12
PCT application publication
(87) Number WO 2015/192030
Date 2015-12-17
Priority applications
(30) Number Date Country code
201462011689 P 2014-06-13 US
Inventors
(72)
PHARES, Ken , US
CHANG, Courtney , US
Grantee
(73) United Therapeutics Corporation , 1040 Spring Street, Silver Spring, MD 20910, US
Title
(54) TREPROSTINIL FORMULATIONS
  TREPROSTINIL FORMULATIONS